Management of juvenile rheumatoid arthritis.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001171:Arthritis, Juvenile / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects; D002648:Child; D002738:Chloroquine / Q000008:administration & dosage / Q000009:adverse effects; D005081:Exercise Therapy; D006046:Gold / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007213:Indomethacin / Q000008:administration & dosage; D010653:Phenylbutazone / Q000008:administration & dosage / Q000009:adverse effects; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D012146:Rest; D013165:Splints; D014606:Uveitis, Anterior / Q000150:complications
D000893:Anti-Inflammatory Agents; D006046:Gold; D002738:Chloroquine; D010653:Phenylbutazone; D001241:Aspirin; D011241:Prednisone; D007213:Indomethacin